Literature DB >> 9442437

Measures of explained variation for a regression model used in survival analysis.

K Akazawa1.   

Abstract

This paper describes a measure of explained variation (MEV) of survival times for a given regression model used in survival analysis. It quantifies the predictive power of a set of prognostic factors in the model, and therefore provides useful information for more precise prediction of patient prognosis, and for designing randomized clinical trials with the capability of determining treatment effects. The MEV defined in this article is asymptotically derived from the squared product-moment correlation; it can be interpreted as an adaptation of the multiple correlation coefficient for the normal linear model to the survival time regression model. Monte-Carlo simulations are performed to investigate the statistical behavior of the proposed MEV. The MEV is applied to estimate the predictive power of several sets of prognostic factors for gastric cancer in Japan using data from a large clinical trial.

Entities:  

Mesh:

Year:  1997        PMID: 9442437     DOI: 10.1023/a:1022884504683

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  15 in total

1.  Prediction in censored survival data: a comparison of the proportional hazards and linear regression models.

Authors:  G Heller; J S Simonoff
Journal:  Biometrics       Date:  1992-03       Impact factor: 2.571

2.  Power of logrank test and Cox regression model in clinical trials with heterogeneous samples.

Authors:  K Akazawa; T Nakamura; Y Palesch
Journal:  Stat Med       Date:  1997-03-15       Impact factor: 2.373

3.  Measures of explained variation for survival data.

Authors:  E L Korn; R Simon
Journal:  Stat Med       Date:  1990-05       Impact factor: 2.373

4.  Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.

Authors:  T Hattori; T Nakajima; H Nakazato; T Tanabe; K Kikuchi; O Abe; T Kondo; T Taguchi; N Komi; K Sugimachi
Journal:  Jpn J Surg       Date:  1990-03

Review 5.  Problems and prediction in survival-data analysis.

Authors:  R Henderson
Journal:  Stat Med       Date:  1995-01-30       Impact factor: 2.373

6.  The relative importance of prognostic factors in studies of survival.

Authors:  M Schemper
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

7.  Confidence intervals for the survival function using Cox's proportional-hazard model with covariates.

Authors:  C L Link
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

8.  The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer.

Authors: 
Journal:  Jpn J Surg       Date:  1981-03

9.  Regression modelling strategies for improved prognostic prediction.

Authors:  F E Harrell; K L Lee; R M Califf; D B Pryor; R A Rosati
Journal:  Stat Med       Date:  1984 Apr-Jun       Impact factor: 2.373

10.  DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.

Authors:  I D'Agnano; C D'Angelo; A Savarese; M Carlini; A Garofalo; L Bottari; E Santoro; D Giannarelli; A Vecchione; G Zupi
Journal:  Lab Invest       Date:  1995-04       Impact factor: 5.662

View more
  1 in total

1.  Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model.

Authors:  Peter C Austin; Michael J Pencinca; Ewout W Steyerberg
Journal:  Stat Methods Med Res       Date:  2015-02-05       Impact factor: 3.021

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.